Low Birth Weight clinical trials

Explore recruiting low birth weight clinical trials.

Recruiting low birth weight studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Low Birth Weight trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prednisolone administration in women with unexplained REcurrent MIscarriages

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Randomised Placebo-Controlled Trial of Early Targeted Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight Infants (ETAPA)

Czechia, Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Extended LH administration (ELHA), a strategy to increase the pool of recruitable antral follicles: a multicentric randomized trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Assisted reproductive technology (ART) and pregnancy outcomes in women with adenomyosis (internal endometriosis) according to stimulation protocol in relation to immunological and endometrial features: a prospective, randomized study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial

Iceland, Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Phase IV, multicenter, open-label, single-arm, open-label study to evaluate the safety of almagate in pregnant women with acidity and heartburn, and on perinatal outcomes in the fetus and newborn

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Low Birth Weight trials by city

Low Birth Weight in Toronto Low Birth Weight in Vancouver Low Birth Weight in Montreal Low Birth Weight in Calgary Low Birth Weight in Edmonton Low Birth Weight in Ottawa Low Birth Weight in Winnipeg Low Birth Weight in Quebec City Low Birth Weight in Hamilton Low Birth Weight in Kitchener Low Birth Weight in London Low Birth Weight in Halifax Low Birth Weight in New York Low Birth Weight in Los Angeles Low Birth Weight in Chicago Low Birth Weight in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease